Home Tags COVID-19 vaccine
Tag: COVID-19 vaccine
In December and January, a long-planned effort to vaccinate essential federal workers was thrown into turmoil, breeding suspicion, infighting, and “shameless” attempts to crash the list.
The WHO’s review found that the Astrazeneca vaccine met the “must-have” criteria for safety, and its efficacy benefits outweighed its risks.
Pfizer's trial in children ages 12-15 is fully enrolled with 2,259 participants.
Access to social media even in remote corners of Brazil has fanned false rumors about the coronavirus vaccines.
President Biden Launches Community Health Centers Vaccination Program
The J & J COVID-19 vaccine requires only one dose
Why are vaccination numbers so low in the U.S,?
Britain on Wednesday became the first country to give emergency authorization to the coronavirus vaccine developed by AstraZeneca and the University of Oxford
Trump Declined COVID-19 Vaccine Doses in November https://twitter.com/businessinsider/status/1338508846940237824?s=20 Health Editor's Note: As late as November Trump was turning away from ordering more COVID-19 vaccines. What was...
The rollout of Covid-19 vaccine could then begin in the United States in a matter of days
A USA TODAY survey finds most states are ready to distribute a coronavirus vaccine to health care workers but maybe not all who are next in line.
The FDA is now reviewing the clinical trial data of the Pfizer and Moderna vaccines to ensure their safety and efficacy.
First authorization for a COVID-19 vaccine represents a breakthrough scientific achievement to help combat this devastating pandemic
Russia is rolling out its Sputnik V vaccine for domestic use despite the fact that late-stage trials have not yet finished
The couple's groundbreaking research in the field of modified genetic code has catapulted them into the public eye
Partner BioNTech received $445 million from German government
Vaccine is more than 90% effective
Moderna anticipates that it may have sufficient data to seek a regulatory OK in November
Never before have we reached herd immunity via natural infection with a novel virus, and COVID-19 is a novel virus.
The development of safe and effective vaccines to prevent SARS-CoV-2 infection and/or COVID-19 is essential to help bring the pandemic under control.
The administration proposed labeling a Covid-19 vaccine authorization a ‘pre-licensure,’ which FDA says would undermine its procedures.
Because of the rapid global spread of SARS-CoV-2 infection and the high mortality rate, development of a vaccine is an urgent task.
None of the candidate vaccines in advanced clinical trials so far has demonstrated a “clear signal” of efficacy at the level of at least 50% sought by the WHO
Yea, get your scientific information from the news media!
The Trump administration said it will not join a global effort to develop, manufacture and equitably distribute a coronavirus vaccine, in part because the World Health Organization is involved.
Re-infection has raised fears about the efficacy of potential vaccines against the virus
Tracking 200 experimental vaccines to combat COVID-19
Russia Claims They are Being Negatively Targeted for Their COVID-19 Vaccine. https://twitter.com/Newsweek/status/1296478624275738624?s=20 Health Editor's Note: The idea that there is an "information war" against the Russian...
Experts have voiced unease over Moscow's rapid approval process for the vaccine.
OWS aims to deliver up to 300 million doses of a safe and effective vaccine for COVID-19 in early 2021, as part of a broader strategy to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics (collectively known as countermeasures).
Trial of 30,000 individuals
According to the World Health Organization’s latest table of COVID-19 vaccines, 124 candidates are at various stages of development with eight different technologies, or platforms.
More than $1bn US BARDA investment to support development and production of the vaccine
The vaccine was developed at the University of Oxford Jenner Institute.
The authors emphasize that developing COVID-19 vaccines will require unprecedented cooperation from governments, academic institutions, industry, and global philanthropic partners